Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Alexander Aldrich

Interventional Cardiology Pickerington, OH Medical Doctor

NPI 1356735278 CMS profile 5103689

1030 Refugee Rd Ste 280, Pickerington, OH 43147

Open in the dashboard

General payments

$7,129

108 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alexander Aldrich of Pickerington, OH is reported in the CMS Open Payments database as having received $7,129 across 108 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 48th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $782 22
2024 General $2,615 52
2023 General $821 17
2022 General $2,882 15
2021 General $28 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexander Aldrich
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Alexander Aldrich were reported at $782. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Alexander Aldrich Interventional Cardiology median Middle half National median
2019 $0 $1,097 $329–$3,048 $163
2020 $0 $473 $161–$1,480 $114
2021 $28 $677 $233–$1,827 $132
2022 $2,882 $978 $333–$2,724 $149
2023 $821 $1,136 $382–$2,986 $160
2024 $2,615 $1,181 $395–$3,326 $164
2025 $782 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $4,278 25 payments
  2. AstraZeneca Pharmaceuticals LP $484 8 payments
  3. Novo Nordisk Inc $377 16 payments
  4. Amgen Inc. $353 14 payments
  5. Abiomed $269 5 payments
  6. Shockwave Medical, Inc $179 1 payment
  7. Novartis Pharmaceuticals Corporation $161 9 payments
  8. Medtronic, Inc. $159 3 payments
  9. Pfizer Inc. $154 8 payments
  10. ZOLL Circulation Inc $150 1 payment
  11. Other $565 18 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,769 100 payments
  2. Travel and Lodging $2,360 8 payments
Products named General payments · program years 2021–2025
  1. General - Vascular Access $1,215 4 payments
  2. AVVIGO Guidance System $504 6 payments
  3. FARXIGA $354 7 payments
  4. Repatha $316 13 payments
  5. Wegovy $266 10 payments
  6. AngioJet Ultra 5000A $248 2 payments
  7. Impella $182 2 payments
  8. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $179 1 payment
  9. ENTRESTO $161 9 payments
  10. OptiCross $150 1 payment
  11. Other $1,946 50 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

178

Median for Interventional Cardiology: 2,236

Drug cost

$21,157

Median for Interventional Cardiology: $380,412

Branded share of claims

19.7%

Median for Interventional Cardiology: 27.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 19 $19,869
Metoprolol Succinate Generic 47 $721
Atorvastatin Calcium Generic 42 $210
Clopidogrel Clopidogrel Bisulfate Brand 16 $156
Carvedilol Generic 28 $116
Losartan Potassium Generic 26 $86

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 4,694 Part D prescribers listed as Interventional Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$36,006

Medicare's payments for the services billed

Medicare patients

252

Average age 74

Services billed

446

124 women, 128 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Ischemic heart disease 57%
Heart failure 45%
Diabetes 44%
Chronic kidney disease 43%
Atrial fibrillation 37%
Depression 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
FARXIGA
  • AstraZeneca Pharmaceuticals LP $326
$326 — —
Repatha
  • Amgen Inc. $265
$265 — —
ENTRESTO
  • Novartis Pharmaceuticals Corporation $89
$89 — —
Ozempic
  • Novo Nordisk Inc $76
$76 — —
LEQVIO
  • Novartis Pharmaceuticals Corporation $53
$53 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

108 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record